Fig. 2From: Effects of Bifidobacterium animalis subsp. lactis BB-12® on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trialChange (%) in the excretion of fecal acetate after 4 weeks of the YS, PRE, POST, or CAPSULE treatment period. Bars are means of the percentage change. Different letters indicate significantly different values based on the mean of the square root transformed data. YS, yogurt smoothie with no BB-12®; PRE, yogurt smoothie with BB-12® added pre-fermentation; POST, yogurt smoothie with BB-12® post-fermentation; SCFAs, short chain fatty acidsBack to article page